Lv41
508 积分 2026-05-15 加入
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma
54分钟前
已完结
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions
7天前
已完结
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
7天前
已完结
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
1个月前
已完结
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
2个月前
已完结
Updated efficacy, safety, and correlative analysis of a phase II trial in metastatic renal cell carcinoma with coordinated pembrolizumab and high dose IL-2
3个月前
已关闭
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
3个月前
已完结
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
3个月前
已完结
Phase Ib study of anlotinib in combination with anti‐PD‐L1 antibody (TQB2450) in patients with advanced acral melanoma
3个月前
已完结
Nivolumab/Relatlimab-rmbw: A Novel Dual Combination Therapy to Treat Adult and Pediatric Patients With Unresectable or Metastatic Melanoma
3个月前
已完结
皖公网安备34019202002308
